Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Notes Payables (2016 - 2022)

CV Sciences' Notes Payables history spans 9 years, with the latest figure at $952000.0 for Q2 2022.

  • On a quarterly basis, Notes Payables fell 68.25% to $952000.0 in Q2 2022 year-over-year; TTM through Jun 2022 was $952000.0, a 68.25% decrease, with the full-year FY2021 number at $612000.0, changed N/A from a year prior.
  • Notes Payables hit $952000.0 in Q2 2022 for CV Sciences, down from $1.0 million in the prior quarter.
  • Over the last five years, Notes Payables for CVSI hit a ceiling of $3.0 million in Q2 2021 and a floor of $66883.0 in Q1 2018.
  • Historically, Notes Payables has averaged $1.0 million across 5 years, with a median of $739409.0 in 2018.
  • Biggest five-year swings in Notes Payables: surged 4663.52% in 2018 and later plummeted 92.04% in 2019.
  • Tracing CVSI's Notes Payables over 5 years: stood at $866818.0 in 2018, then plummeted by 92.04% to $69000.0 in 2019, then surged by 426.09% to $363000.0 in 2020, then surged by 68.6% to $612000.0 in 2021, then skyrocketed by 55.56% to $952000.0 in 2022.
  • Business Quant data shows Notes Payables for CVSI at $952000.0 in Q2 2022, $1.0 million in Q1 2022, and $612000.0 in Q4 2021.